Zongrui Hospital赞助的临床试验
总计101971个结果
-
Jiangsu HengRui Medicine Co., Ltd.完全的乳腺癌 | 中性粒细胞减少症 | 发热性中性粒细胞减少症中国
-
Jiangsu HengRui Medicine Co., Ltd.完全的
-
Peking Union Medical College HospitalJiangsu HengRui Medicine Co., Ltd.招聘中
-
Shanghai Pulmonary Hospital, Shanghai, ChinaJiangsu HengRui Medicine Co., Ltd.尚未招聘
-
Zhigang LiJiangsu HengRui Medicine Co., Ltd.尚未招聘Locally Advanced Resectable Esophageal Squamous Cell Carcinoma中国
-
Qilu Hospital of Shandong UniversityJiangsu HengRui Medicine Co., Ltd.尚未招聘
-
Peking Union Medical College HospitalJiangsu HengRui Medicine Co., Ltd.尚未招聘
-
Jiangsu HengRui Medicine Co., Ltd.Peking University Cancer Hospital & Institute招聘中
-
Shandong Cancer Hospital and InstituteJiangsu HengRui Medicine Co., Ltd.主动,不招人
-
Peking Union Medical College HospitalJiangsu HengRui Medicine Co., Ltd.完全的
-
Tianjin Medical University Second HospitalJiangsu HengRui Medicine Co., Ltd.未知
-
Jiangsu HengRui Medicine Co., Ltd.Shanghai Pulmonary Hospital, Shanghai, China完全的
-
Jiangsu HengRui Medicine Co., Ltd.Peking University Cancer Hospital & Institute未知
-
Peking University Cancer Hospital & InstituteJiangsu HengRui Medicine Co., Ltd.未知
-
Peking Union Medical College HospitalJiangsu HengRui Medicine Co., Ltd.未知
-
Jiangsu HengRui Medicine Co., Ltd.尚未招聘接受基于化疗方案的抗肿瘤治疗且具有中度至高度发热性中性粒细胞减少症 (FN) 风险的非髓系恶性肿瘤患者中国
-
Jiangsu HengRui Medicine Co., Ltd.尚未招聘复杂性尿路感染 (cUTI) 患者,包括急性肾盂肾炎 (AP)
-
Guangdong Hengrui Pharmaceutical Co., Ltd招聘中
-
Jiangsu HengRui Medicine Co., Ltd.尚未招聘HER2 阳性复发性或转移性乳腺癌
-
Jiangsu HengRui Medicine Co., Ltd.招聘中